Arrowhead Pharmaceuticals Inc.
NASDAQ: ARWR
$50.99
-$1.80 (-3.4%)
Closing price January 25, 2022
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including American Water Works, Carnival, Duke Energy, Okta and Zscaler.
5 months ago
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
11 months ago
Last Updated: 5 months ago
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday.
1 year ago
Last Updated: 5 months ago